Akụkọ ụlọ ọrụ

Ịhụ na ahụmihe ọgwụgwọ dị mma ma dị ntụsara ahụ maka ndị ọrịa leukemia gụnyere nlekọta kwa ụbọchị nke ọma, gụnyere ịdị ọcha gburugburu ebe obibi, ịdị ọcha onwe onye, ​​nri na-edozi ahụ, na mmega ahụ kwesịrị ekwesị. Ntuziaka a na-enye ndụmọdụ dị mkpa maka nlekọta dị irè kwa ụbọchị iji kwado mgbake.

Nnyocha e mere n'oge na-adịbeghị anya na-egosi ịdị irè na nchekwa nke ọgwụgwọ sel NS7CAR-T n'ịgwọ nlọghachi azụ ma ọ bụ refractory T-cell nnukwu lymphoblastic leukemia (R/R T-ALL) na T-cell lymphoblastic lymphoma (R/R T-LBL). Usoro ọgwụgwọ a na-enye olileanya ọhụrụ maka ndị ọrịa nwere ụdị ọrịa cancer ndị a siri ike.

A ga-eme mmemme afọ iri na abụọ nke Lu Daopei Hematology na Ọgọst 23-24, 2024, na Beijing International Convention Center. Soro anyị maka mkparịta ụka nwere nghọta na ọganihu ọhụrụ na hematology.

A phase I clinical study of CD7 CAR-T for R/R AML by Daopei Lu's team debuts at ASHThe 65th Annual Meeting of the American Society of Hematology (ASH) mere offline (San Diego, USA) na online na December 9-12, 2023. Ndị ọkà mmụta anyị mere nnukwu ihe ngosi nke ngalaba a ...

American Society of Hematology (ASH) bụ nzukọ agụmakwụkwọ kachasị elu na ngalaba hematology n'ụwa niile. Eziokwu ahụ bụ na ahọpụtara ụlọ ọgwụ Lu Daopei dị ka onye ikpeazụ maka ASH maka afọ sochirinụ na-egosipụta n'ụzọ zuru ezu mmezu agụmakwụkwọ ya na f ...